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H
IV rides the tRNA train to 
the nucleus, according 
to Lyubov Zaitseva, Rich-
ard Myers, and Ariberto Fassati 
(University College, London, UK).
For HIV to propagate in-
side cells, it must ﬁ  rst enter the 
nucleus and, using its reverse 
transcription complex (RTC), in-
tegrate into the host genome. 
Fassati and his team previously 
showed that a nuclear import protein called importin 7 was 
partly responsible for HIV RTC transport to the nucleus.
The team has now set about an unbiased task to ﬁ  nd other 
nuclear import factors. Through multiple cell fractionation steps, 
they identiﬁ   ed an RNA component capable of supporting 
nuclear import of HIV RTC. Sequencing revealed that the 
component was tRNA. Sure that tRNAs—instrumental for cyto-
plasmic protein translation—could not be responsible, Fassati 
thought, “Oh no! It’s all wrong, we’ve got to start all over 
again.” Only after multiple repetitions was the team convinced 
that the tRNA was not merely a contaminant.
Virtually all the tRNAs isolated from the active fraction (the 
one capable of nuclear import) had defective 3′ ends and were 
thus incapable of supporting translation. Wild-type tRNAs, on 
the other hand, had very little nuclear import activity.
Fassati speculates that perhaps the defective tRNAs get 
shuttled back to the nucleus for repair or degradation. Nuclear 
import costs energy, but the expense is probably worthwhile to 
ensure undisturbed protein translation. Whatever the host cell’s 
cost, HIV enjoys a free ride.
Reference: Zaitseva, L., et al. 2006. PLoS. 4:1689–1706.
Point of no return 
for senescence
S
enescent cells live on but can never 
again divide. This proliferative block is 
thought to safeguard against rampant 
oncogenic cell division. Akiko Takahashi, Eiji 
Hara, and colleagues (University of Tokushima, 
Japan) now show that, to enforce this irreversible 
stasis, cells switch on a self-perpetuating loop 
that suppresses cytokinesis.
Stable cell cycle arrest is induced by acti-
vating the retinoblastoma (RB) tumor suppressor. 
In senescent human cells, unlike nonsenescent 
cells, subsequent inactivation of RB leads to 
the reinitiation of DNA replication but no prolif-
eration, suggesting that a second safety mechanism 
arrests senescent cells in G2 or M phase.
This second arrest only works in cells that 
are grown in mitogen-rich (and thus tumor friendly) 
conditions, the authors now ﬁ  nd. The mitogens 
induce reactive oxygen species (ROS), which 
then start a self-perpetuating loop. The team 
observed that ROS remained high in senescent 
cells even after RB inactivation.
ROS, which are thought to induce senes-
cence, are known to activate PKCδ, which studies 
suggest in turn activates ROS production. Consis-
tent with this positive feedback, levels of PKCδ 
were also high in the permanently arrested cells.
High PKCδ, the team showed, suppressed 
the WARTS cytokinesis activator. Inhibiting PKCδ 
released this suppression and enabled senescent 
cells that managed to escape the early RB-induced 
block to proliferate.




he destructive force of the proteasome is tempered by one of its 
own components, report John Hanna, Daniel Finley, and colleagues 
(Harvard Medical School, Boston, MA).
The traditional view of the proteasome was, says Finley, “like a 
pencil sharpener,” mindlessly chewing away at ubiquitinated proteins. 
The characterization of one proteasome-associated factor now changes 
that view. Ubp6, the team shows, actually delays the rate of protein 
destruction. Proteasomes purifi  ed from yeast Ubp6 deletion mutants 
degraded ubiquitinated cyclin B protein faster than did those from 
their wild-type counterparts.
Ubp6 is a deubiquitinase, but this activity was not responsible for 
delaying degradation. Inhibiting its deubiquitinase active site did not 
speed up degradation. Ubp6 also needed to be bound to the proteasome 
to delay degradation, which would not be necessary if the delay 
tactic was simply to prevent 
targeting of proteins to the 
proteasome by removing 
ubiquitin moieties.
Instead, Ubp6 seems to 
delay degradation, at least in 
part, by inhibiting the action 
of a second proteasome com-
ponent, called Rpn11. Rpn11 
is itself a deubiquitinase 
whose activity is strictly 
coupled with degradation, 
unlike Ubp6.
Though Rpn11 inhibition 
might not be the sole cause for 
the degradation delay, it is clear 
that the proteasome is a more 
fi  nely self-tuning machine than 
was fi  rst thought.
Reference: Hanna, J., et al. 2006. 
Cell. 127:99–111.
tRNA transport to the nucleus
With Ubp6, degradation of a ubiquiti-
















HIV RTC accumulation in the 
nucleus (top) fails without 
tRNA (bottom).
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